• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于蛋白质类药物控制释放的重组蜘蛛丝颗粒。

Recombinant spider silk particles for controlled delivery of protein drugs.

机构信息

Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University, Munich, Germany.

出版信息

Biomaterials. 2012 Feb;33(5):1554-62. doi: 10.1016/j.biomaterials.2011.10.053. Epub 2011 Nov 9.

DOI:10.1016/j.biomaterials.2011.10.053
PMID:22079006
Abstract

The engineered and recombinant spider silk protein eADF4(C16) has been shown to be a promising biomaterial for the use as drug delivery system. In previous studies, eADF4(C16) particles were loaded with low molecular weight drugs exhibiting a positive net-charge and sufficient hydrophobicity. Here, we demonstrate that also macromolecular drugs like proteins can be loaded on eADF4(C16) particles. Using lysozyme as a model protein, remarkably high loading of up to 30% [w/w] was feasible and high loading efficiencies of almost 100% were obtained. Furthermore, using confocal laser scanning microscopy, it is demonstrated that fluorescently labeled lysozyme is not only adsorbed to the negatively charged particles' surface, but also diffusing into the matrix of eADF4(C16) particles. The release of lysozyme is shown to be dependent on the ionic strength and pH of the release medium. To improve the long-term stability of eADF4(C16) containing dispersions, lyophilization is shown as a suitable tool. Disaccharides (sucrose, trehalose) and mannitol served as stabilizers to prevent aggregation and/or particle degradation during freeze-drying. The slowly biodegradable eADF4(C16) particles are a promising new particulate drug carrier system for the delivery of susceptible drugs like therapeutic proteins.

摘要

工程化和重组蜘蛛丝蛋白 eADF4(C16) 已被证明是一种很有前途的生物材料,可作为药物传递系统。在以前的研究中,eADF4(C16) 颗粒负载带正净电荷和足够疏水性的低分子量药物。在这里,我们证明了像蛋白质这样的大分子药物也可以负载到 eADF4(C16) 颗粒上。使用溶菌酶作为模型蛋白,可实现高达 30%[w/w]的高负载量,并且几乎可以达到 100%的高负载效率。此外,使用共聚焦激光扫描显微镜,证明荧光标记的溶菌酶不仅吸附在带负电荷的颗粒表面,而且还扩散到 eADF4(C16)颗粒的基质中。溶菌酶的释放被证明依赖于释放介质的离子强度和 pH 值。为了提高含有 eADF4(C16)的分散体的长期稳定性,冻干被证明是一种合适的工具。二糖(蔗糖、海藻糖)和甘露醇用作稳定剂,以防止在冷冻干燥过程中聚集和/或颗粒降解。缓慢可生物降解的 eADF4(C16)颗粒是一种有前途的新型颗粒药物载体系统,可用于输送易受影响的药物,如治疗性蛋白质。

相似文献

1
Recombinant spider silk particles for controlled delivery of protein drugs.用于蛋白质类药物控制释放的重组蜘蛛丝颗粒。
Biomaterials. 2012 Feb;33(5):1554-62. doi: 10.1016/j.biomaterials.2011.10.053. Epub 2011 Nov 9.
2
Recombinant spider silk particles as drug delivery vehicles.重组蜘蛛丝颗粒作为药物传递载体。
Biomaterials. 2011 Mar;32(8):2233-40. doi: 10.1016/j.biomaterials.2010.11.060. Epub 2010 Dec 24.
3
Cellular uptake of drug loaded spider silk particles.载药蜘蛛丝颗粒的细胞摄取。
Biomater Sci. 2016 Sep 20;4(10):1515-1523. doi: 10.1039/c6bm00435k.
4
Processing conditions for the formation of spider silk microspheres.蜘蛛丝微球形成的加工条件。
ChemSusChem. 2008;1(5):413-6. doi: 10.1002/cssc.200800030.
5
Engineering of recombinant spider silk proteins allows defined uptake and release of substances.重组蜘蛛丝蛋白的工程化使得物质能够有明确的摄取和释放。
J Pharm Sci. 2015 Mar;104(3):988-94. doi: 10.1002/jps.24300. Epub 2014 Dec 27.
6
Controlled hydrogel formation of a recombinant spider silk protein.控制重组蜘蛛丝蛋白的水凝胶形成。
Biomacromolecules. 2011 Jul 11;12(7):2488-95. doi: 10.1021/bm200154k. Epub 2011 Jun 7.
7
The effect of steam sterilization on recombinant spider silk particles.蒸汽灭菌对重组蛛丝颗粒的影响。
Int J Pharm. 2015 Mar 15;481(1-2):125-31. doi: 10.1016/j.ijpharm.2015.01.024. Epub 2015 Jan 14.
8
Enhanced cellular uptake of engineered spider silk particles.增强型工程蜘蛛丝颗粒的细胞摄取。
Biomater Sci. 2015 Mar;3(3):543-51. doi: 10.1039/c4bm00401a. Epub 2015 Jan 13.
9
Water-based preparation of spider silk films as drug delivery matrices.作为药物递送基质的蜘蛛丝膜水基制剂。
J Control Release. 2015 Sep 10;213:134-141. doi: 10.1016/j.jconrel.2015.06.025. Epub 2015 Jun 20.
10
Intrinsic Vascularization of Recombinant eADF4(C16) Spider Silk Matrices in the Arteriovenous Loop Model.在动静脉环模型中重组 eADF4(C16) 蜘蛛丝基质的内在血管化。
Tissue Eng Part A. 2019 Nov;25(21-22):1504-1513. doi: 10.1089/ten.TEA.2018.0360. Epub 2019 May 2.

引用本文的文献

1
Preparation and characterization of a iRGD-modified recombinant spider silk particles for antitumor polypeptide drug delivery into cancer cells.用于将抗肿瘤多肽药物递送至癌细胞的iRGD修饰重组蜘蛛丝颗粒的制备与表征
BMC Biotechnol. 2025 Aug 27;25(1):88. doi: 10.1186/s12896-025-01023-y.
2
Delivery of Polypeptide Drugs Using Nanoparticles Made of Recombinant Spider Silks Derived From MaSp4 Protein.使用源自MaSp4蛋白的重组蜘蛛丝制成的纳米颗粒递送多肽药物。
Int J Nanomedicine. 2025 Mar 3;20:2609-2622. doi: 10.2147/IJN.S510273. eCollection 2025.
3
Spider minor ampullate silk protein nanoparticles: an effective protein delivery system capable of enhancing systemic immune responses.
微小壶腹蛛丝蛋白纳米颗粒:一种能够增强全身免疫反应的有效蛋白质递送系统。
MedComm (2020). 2024 Jun 15;5(7):e573. doi: 10.1002/mco2.573. eCollection 2024 Jul.
4
A recombinant chimeric spider pyriform-aciniform silk with highly tunable mechanical performance.一种具有高度可调机械性能的重组嵌合蜘蛛梨状-葡萄状丝。
Mater Today Bio. 2024 Apr 27;26:101073. doi: 10.1016/j.mtbio.2024.101073. eCollection 2024 Jun.
5
Severe Obesity Is an Independent Risk Factor of Early Readmission and Nonhome Discharge After Cervical Disc Replacement.重度肥胖是颈椎间盘置换术后早期再入院和非家庭出院的独立危险因素。
Neurospine. 2023 Sep;20(3):890-898. doi: 10.14245/ns.2346442.221. Epub 2023 Sep 30.
6
Towards engineering and production of artificial spider silk using tools of synthetic biology.利用合成生物学工具实现人工蜘蛛丝的工程化与生产。
Eng Biol. 2020 Mar 16;4(1):1-6. doi: 10.1049/enb.2019.0017. eCollection 2020 Mar.
7
Research progress of natural silk fibroin and the application for drug delivery in chemotherapies.天然丝素蛋白的研究进展及其在化疗药物递送中的应用
Front Pharmacol. 2023 Jan 4;13:1071868. doi: 10.3389/fphar.2022.1071868. eCollection 2022.
8
Tailor-made spider-eggcase-silk spheres for efficient lysosomal drug delivery.用于高效溶酶体药物递送的定制蜘蛛卵囊丝球体
RSC Adv. 2018 Mar 6;8(17):9394-9401. doi: 10.1039/c8ra00232k. eCollection 2018 Feb 28.
9
Impacts of Blended Silk Fibroin and Recombinant Spider Silk Fibroin Hydrogels on Cell Growth.混合丝素蛋白与重组蜘蛛丝素蛋白水凝胶对细胞生长的影响
Polymers (Basel). 2021 Nov 29;13(23):4182. doi: 10.3390/polym13234182.
10
Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy.用于癌症治疗的基于丝的全身和局部给药系统。
Cancers (Basel). 2021 Oct 27;13(21):5389. doi: 10.3390/cancers13215389.